MEHCQ (Chrome Holding Co) Return-on-Tangible-Equity: 0.00% (As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEHCQ Chrome Holding Co MEHCQ
58 GF Score
Price $3.50
View Full Analysis

What is Chrome Holding Co Return-on-Tangible-Equity?

Chrome Holding Co MEHCQ -2.78% 58 Return-on-Tangible-Equity is 0.00% as of Jun. 2025. GuruFocus rates MEHCQ with a GF Score™ of 58/100.

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Chrome Holding Co's annualized net income for the quarter that ended in Jun. 2025 was $-95.3 Mil. Chrome Holding Co's average shareholder tangible equity for the quarter that ended in Jun. 2025 was $-78.4 Mil. Therefore, Chrome Holding Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 was N/A%.

The historical rank and industry rank for Chrome Holding Co's Return-on-Tangible-Equity or its related term are showing as below:

MEHCQ's Return-on-Tangible-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.34
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Chrome Holding Co  (OTCPK:MEHCQ) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Chrome Holding Co Return-on-Tangible-Equity Related Terms


Chrome Holding Co Return-on-Tangible-Equity Historical Data

* Premium members only.

The historical data trend for Chrome Holding Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chrome Holding Co Return-on-Tangible-Equity Chart

Chrome Holding Co Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Return-on-Tangible-Equity
Get a 7-Day Free Trial 0.00 0.00 -79.77 -305.99 -887.81

Chrome Holding Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -327.63 -634.81 0.00 0.00 0.00

MEHCQ vs BDSX, XGN, FONR: Return-on-Tangible-Equity Comparison

For the Diagnostics & Research subindustry, Chrome Holding Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chrome Holding Co Return-on-Tangible-Equity vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Chrome Holding Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Chrome Holding Co's Return-on-Tangible-Equity falls into.


MEHCQ
58GF Score
Chrome Holding Co MEHCQ
Return-on-Tangible-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Chrome Holding Co Return-on-Tangible-Equity Calculation

Chrome Holding Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=-280.885/( (134.749+-71.473 )/ 2 )
=-280.885/31.638
=-887.81 %

Chrome Holding Co's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2025 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2025 )  (Q: Mar. 2025 )(Q: Jun. 2025 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2025 )  (Q: Mar. 2025 )(Q: Jun. 2025 )
=-95.312/( (-71.473+-85.281)/ 2 )
=-95.312/-78.377
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2025) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.

What does a Return-on-Tangible-Equity of 0.00% mean?
Chrome Holding Co (MEHCQ) has a Return-on-Tangible-Equity of 0.00% as of Jun. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chrome Holding Co and its competitors.
Is Chrome Holding Co's Return-on-Tangible-Equity too high?
Chrome Holding Co's current Return-on-Tangible-Equity is 0.00%. Overall, Chrome Holding Co has a GF Score™ of 58/100, reflecting its overall financial health beyond just this single metric.
How does Chrome Holding Co's Return-on-Tangible-Equity compare to BDSX and XGN?
Chrome Holding Co's Return-on-Tangible-Equity of 0.00% can be compared against companies in the Medical Diagnostics & Research industry. The industry median Return-on-Tangible-Equity is 0.34. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Diagnostics & Research company?
The median Return-on-Tangible-Equity among Medical Diagnostics & Research companies is 0.34, based on 189 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Chrome Holding Co and its competitors. For the Medical Diagnostics & Research industry, the median Return-on-Tangible-Equity is 0.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chrome Holding Co's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chrome Holding Co stock overvalued right now?
Chrome Holding Co (MEHCQ) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Chrome Holding Co's overall GF Score™ is 58/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Chrome Holding Co (MEHCQ), the current Return-on-Tangible-Equity is 0.00% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Chrome Holding Co Business Description

Address 870 Market Street, Room 415, South San Francisco, CA, USA, 94102
Chrome Holding Co, formerly known as 23andMe Holding Co, is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes one main sector that is Consumer and Research Services. The company generates maximum revenue from the Consumer and Research Services segment.
58GF Score

Get the complete analysis for MEHCQ

Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.50
Price